OOIR: Observatory of International Research

Papers

(The TQCC of Clinical and Translational Radiation Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The technical design and concept of a PET/CT linac for biology-guided radiotherapy	36
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator	26
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer	23
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance	23
Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry	23
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience	20
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients	19
CDK 4/6 inhibitors combined with radiotherapy: A review of literature	19
Radiomic biomarkers of tumor immune biology and immunotherapy response	18
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients	17
Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy	16
Whole Brain Irradiation or Stereotactic RadioSurgery for five or more brain metastases (WHOBI-STER): A prospective comparative study of neurocognitive outcomes, level of autonomy in daily activities a	16
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)	16
Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy	15
Auto-segmentations by convolutional neural network in cervical and anorectal cancer with clinical structure sets as the ground truth	14
Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma	13
The changing role of radiation oncology professionals in a world of AI – Just jobs lost – Or a solution to the under-provision of radiotherapy?	12
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center cli	12
X-rays minibeam radiation therapy at a conventional irradiator: Pilot evaluation in F98-glioma bearing rats and dose calculations in a human phantom	12
1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation	11
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies	11
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer	11
MR-guided stereotactic body radiation therapy for intracardiac and pericardial metastases	10
Analysis of the electron-stream effect in patients treated with partial breast irradiation using the 1.5 T MR-linear accelerator	10
GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer	10

Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume	10
Estimated clinical benefit of combining highly conformal target volumes with Volumetric-Modulated Arc Therapy (VMAT) versus conventional flank irradiation in pediatric renal tumors	10
Breast cancer radiation therapy: A bibliometric analysis of the scientific literature	9
ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in primary locally advanced rectal cancer	9
Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac	9
Lattice Radiation Therapy in clinical practice: A systematic review	9
Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer	9
Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review	9
Large anatomical changes in head-and-neck cancers – A dosimetric comparison of online and offline adaptive proton therapy	8
Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study	8
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database	8
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) – A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gas	8
Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma	8
Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma	8
Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial	8
Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy	8
A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology	8
Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer	8
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer	8
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab	7
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI	7
A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS	7
European radiation oncology after one year of COVID-19 pandemic	7
Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study	7
Cardiac radioablation in the treatment of ventricular tachycardia	7
Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up	7
The role of dietary supplements, including biotics, glutamine, polyunsaturated fatty acids and polyphenols, in reducing gastrointestinal side effects in patients undergoing pelvic radiotherapy: A syst	7
Auto-detection and segmentation of involved lymph nodes in HPV-associated oropharyngeal cancer using a convolutional deep learning neural network	7
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey	7
Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016–2018	7
PROMIS scores of patients undergoing neoadjuvant and adjuvant radiation therapy for surgically excised soft tissue sarcoma	7
High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis	7
Pseudo-siamese network combined with dosimetric and clinical factors, radiomics features, CT images and 3D dose distribution for the prediction of radiation pneumonitis: A feasibility study	6
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy	6
High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose calculation	6
Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer	6
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group	6
The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy	6
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise	6
Prospective study of artificial intelligence-based decision support to improve head and neck radiotherapy plan quality	6
Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients	6
Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework	6
Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation	6
Voluntary versus ABC breath-hold in the context of VMAT for breast and locoregional lymph node radiotherapy including the internal mammary chain	6
Late toxicity in the brain after radiotherapy for sinonasal cancer: Neurocognitive functioning, MRI of the brain and quality of life	6
Prediction models for treatment-induced cardiac toxicity in patients with non-small-cell lung cancer: A systematic review and meta-analysis	6
High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes	6
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer	6
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach	6
Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer	6

A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic	6
Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose	5
Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review	5
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial	5
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study	5
Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly	5
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre	5
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis	5
Proton therapy of a pregnant patient with nasopharyngeal carcinoma	5
Artificial intelligence to predict outcomes of head and neck radiotherapy	5
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)	5
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer	5
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma	4
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal	4
Redefining postmastectomy radiation contouring in the era of immediate breast reconstruction: An accurate assessment of local recurrence risk	4
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence	4
Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale	4
The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas	4
Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies	4
Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer	4
Machine learning for normal tissue complication probability prediction: Predictive power with versatility and easy implementation	4
Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients	4
The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis	4
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan	4
Adaptive radiotherapy for breast cancer	4
Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adap	4
MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study	4
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study	4
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer	4
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy	4
Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study	4
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives	4
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer	4
Impact of transitioning to an online course – A report from the ESTRO gyn teaching course	4
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis	4
Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients?	4
Optimal timing of radiotherapy in high risk prostate cancer: Do missed days matter?	4
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk	4
A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT)	4
Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre	4
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma	4
Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control	4
Radiotherapy and olaparib in combination for carcinoma of the oesophagus: A phase I study	4
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids	4
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial	4
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival	4
Prolonging deep inspiration breath-hold time to 3 min during radiotherapy, a simple solution	4
Magnetic resonance imaging-derived radiomic signature predicts locoregional failure after organ preservation therapy in patients with hypopharyngeal squamous cell carcinoma	3
Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience	3
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer	3
Inhalation anesthesia and shielding devices to allow accurate preclinical irradiation of mice with clinical linac-based systems: Design and dosimetric characteristics	3
Adjuvant locoregional radiation therapy in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy: A systematic review and meta-analysis	3
Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer	3
Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial	3
AI-assisted clinical decision making (CDM) for dose prescription in radiosurgery of brain metastases using three-path three-dimensional CNN	3
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009	3
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience	3
The safety and efficacy of a novel hypo-fractionated total marrow and lymphoid irradiation before allogeneic stem cell transplantation for lymphoma and acute leukemia	3
Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer	3
Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry	3
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases	3
Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study	3
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy	3
Radiation therapy for primary orbital and ocular adnexal lymphoma	3
Novel unconventional radiotherapy techniques: Current status and future perspectives – Report from the 2nd international radiation oncology online seminar	3
Radiotherapy for pediatric adrenocortical carcinoma – Review of the literature	3
Extraction parameter optimized radiomics for neoadjuvant chemotherapy response prognosis in advanced nasopharyngeal carcinoma	3
Reduction of intrafraction pancreas motion using an abdominal corset compatible with proton therapy and MRI	3
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study	3
MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving?	3
Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis	3
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study	3
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma	3
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study	3
Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer	3
Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis	3
Air variability in maxillary sinus during radiotherapy for sinonasal carcinoma	3
Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation	3
The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey	3
The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?	3